KIORA PHARMACEUTICALS INC (KPRX) › Operating IncomeKIORA PHARMACEUTICALS INC (KPRX) — Operating IncomeAnnual figures by period end, from SEC filings.2018-12-31: -$10.84M2020-12-31: -$6.87M2021-12-31: -$14.24M2022-12-31: -$12.31M2023-12-31: -$12.59M2024-12-31: $4.51M2025-12-31: -$12.83M-$12.83M2018-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$12.83M-384.5%2026-03-25From 2025-01-012024-12-31$4.51M—2026-03-25From 2024-01-012023-12-31-$12.59M—2025-03-25From 2023-01-012022-12-31-$12.31M—2024-03-25From 2022-01-012021-12-31-$14.24M—2023-03-23From 2021-01-012020-12-31-$6.87M—2022-07-07From 2020-01-012018-12-31-$10.84M—2019-03-01From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)